DTIL vs KYTX: stock comparison and AI forecast
Precision Biosciences Inc (DTIL) and Kyverna Therapeutics, Inc. (KYTX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
DTIL Precision Biosciences Inc
- Market Cap
- $293M
- P/E Ratio
- 9.8x
- Size
- small-cap
- AI Forecast
KYTX Kyverna Therapeutics, Inc.
- Market Cap
- $302M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- DTIL and KYTX have similar market capitalizations ($293M and $302M).
- DTIL carries 1.32 times debt per unit of equity, against 0.33 times for KYTX.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | DTIL | KYTX |
|---|---|---|
| Market Cap | $293M | $302M |
| P/E Ratio | 9.82x | – |
| P/B Ratio | 5.65x | 1.82x |
| EPS | $1.08 | $-2.27 |
| Book Value/Share | $1.88 | $2.68 |
| Revenue/Share | $1.63 | – |
| FCF/Share | $-1.87 | – |
Profitability & Margins
| Metric | DTIL | KYTX |
|---|---|---|
| ROE | – | -92.2% |
| ROA | – | -69.4% |
| ROIC | -32.2% | -80.7% |
| Operating Margin | -80.3% | – |
| EBT Margin | -57.6% | – |
Financial Health
| Metric | DTIL | KYTX |
|---|---|---|
| Current Ratio | 10.47x | 9.06x |
| D/E Ratio | 1.32x | 0.33x |
| Financial Leverage | 2.32x | 1.33x |
| Interest Coverage | -67.6x | -69.0x |
| Working Capital | $78M | $184M |
Cash Flow
| Metric | DTIL | KYTX |
|---|---|---|
| Operating Cash Flow | -$52M | -$159M |
| Free Cash Flow | -$52M | – |
| Capital Spending | $60K | – |
| FCF/Sales | -114.8% | – |
| CapEx/Sales | 0.1% | – |
Operational Efficiency
| Metric | DTIL | KYTX |
|---|---|---|
| Asset Turnover | 0.37x | – |
| Fixed Assets Turnover | 57.8x | – |
| Days Sales Outstanding | 0 days | – |
Income Statement
| Metric | DTIL | KYTX |
|---|---|---|
| Total Revenue | $45M | – |
| Operating Income | -$36M | -$159M |
| Net Income | – | -$153M |
| R&D Expense | $53M | $115M |
Dividend & Shareholder Information
| Metric | DTIL | KYTX |
|---|---|---|
| Shares Outstanding | 28M | 62M |
DTIL vs KYTX: stock comparison and AI forecast
Which is bigger, DTIL or KYTX?
DTIL and KYTX have similar market capitalizations ($293M and $302M).
Which one does Intratio's AI model rank higher, DTIL or KYTX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.